MeSH tree: D20.215.894.135.825.100
Researchers from the Butantan Institute and collaborators are developing a more potent version of the BCG vaccine that protects against tuberculosis. While the conventional immunizer reduced infection by 90% in experiments ...
Jul 3, 2024
0
35
In a critical global public health development, a candidate vaccine for tuberculosis (TB) has been created using a gene-editing approach.
Jun 19, 2024
0
64
In new research, investigators at Massachusetts General Hospital (MGH) show that the 100-year-old Bacillus Calmette-Guérin (BCG) vaccine, originally developed to prevent tuberculosis, protects individuals with type 1 diabetes ...
May 22, 2024
0
86
A team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people than any other.
Apr 29, 2024
0
51
The U.S. Food and Drug Administration (FDA) has approved the immunotherapy-boosting drug N-803, which is marketed under the brand name Anktiva, to be used in combination with the immunotherapy Bacillus Calmette-Guerin (BCG) ...
Apr 23, 2024
0
40
University of Oxford researchers have for the first time established a controlled human infection model for tuberculosis (TB) that infects people via the lungs—the way TB enters the body.
Apr 15, 2024
0
58
Every year, 10 million people fall ill with tuberculosis. Even though the disease is both preventable and curable, it kills 1.5 million people each year, making it the world's deadliest infectious disease. Over 25% of these ...
Mar 25, 2024
1
30
A new study from the School of Nursing and Midwifery, Trinity College Dublin has explored the effects of stopping universal Bacillus Calmette-Guérin (BCG) vaccination in Ireland. The study was recently published in the journal ...
Mar 25, 2024
0
32
As Canada's flu season collides with record strep A cases and ongoing COVID-19 concerns, a new study is shedding light on our understanding of respiratory immune responses. Scholars from the Research Institute of the McGill ...
Feb 22, 2024
0
38
A UC Davis Health study found that a single dose of Bacillus Calmette-Guérin (BCG), the vaccine for tuberculosis (TB), reduced liver tumor burden and extended the survival of mice with liver cancer. The study, published in ...
Feb 21, 2024
0
67
